COVID-19 in Patients with Chronic Myeloid Leukemia: Poor Outcomes for Patients with Comorbidities, Older Age, Advanced Phase Disease, and Those from Low-Income Countries: An Update of the Candid Study

Background The iCMLf CANDID study represents the largest global cohort study to date characterizing COVID-19 in CML. This real world data collection, from 157 institutions in 49 countries, is essential to differentiate impact of patient, disease, and therapy specific factors on risk and outcomes, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagnano, Katia B, Kok, Chung Hoow, Mauro, Michael J., Cortes, Jorge E., Evans, Nicola, Jiang, Qian, Milojkovic, Dragana, Moiraghi, Beatriz, Nicolini, Franck E., Ongondi, Matilda, Zackova, Daniela, Rea, Delphine, Hughes, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
632.Chronic Myeloid Leukemia: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701653/
http://dx.doi.org/10.1182/blood-2021-150026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701653/
http://dx.doi.org/10.1182/blood-2021-150026

Ejemplares similares